Cash Flow from Operating Activities: A company's cash flows from operations.
Sarepta Therapeutics, Inc. (SRPT) Cash Flow from Operating Activities data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.20B |
|
$-713.41M |
|
$839.61M |
|
$1.36B |
|
$2.90B |
|
$-699.78M |
|
$-2.44M |
|
$-702.23M |
|
$-702.23M |
|
$-713.41M |
|
$-713.41M |
|
$-713.41M |
|
$-713.41M |
|
$-699.78M |
|
$-699.78M |
|
100.12M |
|
100.12M |
|
$-7.13 |
|
$-7.13 |
|
| Balance Sheet Financials | |
$2.54B |
|
$345.12M |
|
$811.76M |
|
$3.35B |
|
$1.10B |
|
$828.97M |
|
$1.11B |
|
$2.21B |
|
$1.14B |
|
$1.14B |
|
$1.14B |
|
104.96M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|